DelveInsight's "Eosinophilic Gastroenteritis (EGE) Market Insights, Epidemiology, and Market Forecast 2032" reports deliver an in-depth understanding of the disease, historical and forecasted epidemiology, the pipeline insight as well as the Eosinophilic Gastroenteritis (EGE) market size and shares analysis in the seven major markets (7MM).
The report also covers emerging therapies, current treatment practices, Eosinophilic Gastroenteritis (EGE) Market Shares of the individual therapies, a detailed current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assess the underlying potential of the market.
Eosinophilic Gastroenteritis (EGE) Disease: An Overview
Eosinophilic Gastroenteritis (EGE) is a rare digestive disease characterized by the triad of eosinophilic infiltration of segments of the gastrointestinal tract, abnormalities of gastrointestinal function (varying from dyspepsia and obstruction to diarrhea and ascites), and exclusion of other diseases with peripheral eosinophilia.
- In 2020, among the 7MM, the Eosinophilic Gastroenteritis prevalent cases were highest in the US, with 30,133 cases, and the lowest in Spain with 2,695 cases.
- Among EU5 countries, Germany had the highest number of prevalent cases of eosinophilic gastroenteritis (4,329 cases) in 2020.
- In the United States, EGE is considered very rare, with an estimated prevalence of 8.2/100,000.
- In Japan, eosinophilic gastrointestinal disorder (EGID) is an intractable disease designated by the Ministry of Health, Labor, and Welfare from 2015. According to a report by the research group, there are more than 5,000 patients in Japan. As per their annual report, 700 incident patients are being treated for EGIDs in Japan.
Eosinophilic Gastroenteritis (EGE) Market
As per DelveInsight, the Eosinophilic Gastroenteritis (EGE) Market size in the 7MM was found to be USD 109.3 million in 2020, which is expected to increase owing to the growing awareness, improved management, and better outcomes. DelveInsight’s analysts estimate that the market is expected to show positive growth, mainly attributed to increased prevalence and the anticipated launch of novel therapies during the forecast period.
Eosinophilic Gastroenteritis (EGE) Market Outlook
The Eosinophilic Gastroenteritis (EGE) market analysis section of the report helps to understand the current and forecasted Eosinophilic Gastroenteritis (EGE) Market Trends and Growth by evaluating the impact of current therapies on the market, unmet needs, drivers, and barriers.
The report gives complete detail of Eosinophilic Gastroenteritis (EGE) Market Size and Shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Eosinophilic Gastroenteritis (EGE) Therapeutics Market
The Eosinophilic Gastroenteritis (EGE) Market has a promising outlook with some of the best potential emerging therapies in the pipeline expected to launch in the coming years.
Some of the key companies in the Eosinophilic Gastroenteritis (EGE) Market.
- AstraZeneca
- Allakos
And others
Eosinophilic Gastroenteritis (EGE) Therapies covered in the report include:
- Lirentelimab
- Benralizumab
- Esomeprazole + Budesonide
And Others
Eosinophilic Gastroenteritis (EGE) Pipeline Insights
The Eosinophilic Gastroenteritis (EGE) Pipeline and Drugs Uptake section focus on the rate of uptake of the market therapies as well as the therapies expected to get launch in the coming years. The analysis covers the Eosinophilic Gastroenteritis (EGE) Market uptake by drugs, patient uptake by therapies, and drug sales.
Report’s drugs uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the Eosinophilic Gastroenteritis (EGE) Therapies based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Report Key Strengths
- 10-years Forecast
- 7MM Coverage
- Key Competitors
- Highly Analyzed Market
- Drugs Uptake
- Epidemiology Segmentation
For more details, visit: Eosinophilic Gastroenteritis (EGE) Market Share